What Are HIV Post-Exposure Prophylaxis (PEP) Medications?
Sep 07, 2021
Source: Cainiu Health
Dr. Wang Jihong
Introduction
It is recommended to initiate treatment within 24 hours—ideally within 2 hours—for optimal efficacy. However, antiretroviral prophylaxis is still advised even if initiated beyond 24 hours; the duration of treatment should be 28 days. The preferred regimen consists of tenofovir and emtricitabine (two nucleoside reverse transcriptase inhibitors) combined with an integrase inhibitor—either raltegravir or dolutegravir.
HIV refers to the human immunodeficiency virus, and HIV post-exposure prophylaxis (PEP) drugs are medications designed to prevent HIV infection. These drugs work by inhibiting the virus’s ability to establish itself in the body, thereby preventing infection—but optimal efficacy depends strictly on correct use. Consequently, there are numerous important considerations when using HIV PEP. So, what exactly are HIV PEP drugs? The following section provides a detailed explanation.
What Are HIV Post-Exposure Prophylaxis (PEP) Drugs?
HIV PEP refers to the administration of antiretroviral drugs following a potential exposure event that could lead to HIV infection, with the aim of reducing the risk of transmission. It is recommended to initiate PEP within 24 hours of exposure—ideally within 2 hours—for maximum effectiveness. Even if more than 24 hours have elapsed, PEP should still be initiated, and treatment must be continued for a full 28 days. Recommended PEP regimens may vary slightly across guidelines but generally involve combining two nucleoside reverse transcriptase inhibitors (NRTIs) with an antiretroviral drug from another class. The preferred first-line regimen consists of tenofovir and emtricitabine (both NRTIs), combined with an integrase strand transfer inhibitor (INSTI), such as raltegravir or dolutegravir.
Additional Information: Key Considerations When Taking HIV PEP
1. Because monitoring for both adverse effects and prophylactic efficacy is essential during PEP, regular follow-up testing is critically important. Typically, liver and kidney function tests should be performed two weeks after initiating PEP. HIV antibody testing is recommended at one month and three months post-exposure. A negative result at the three-month mark confirms successful PEP.
2. Common side effects of PEP drugs include dizziness, nausea, fatigue, and loss of appetite; viral rash may occur occasionally but is rare. Efavirenz—though less commonly used in current PEP regimens—may cause neurological symptoms such as headache, vivid dreams, or depression, and is contraindicated in pregnancy. During PEP, sexual activity should be minimized, and consistent condom use is mandatory to avoid further high-risk exposures.
The above outlines what HIV PEP drugs are. We hope this information is helpful to you.
